Similar results have been observed for the melanoma cell line OCM-1A where bisulfite sequencing revealed methylation of 87% of CpG sites in the promoter region of HLA-G before treatment compared to only 2% after treatment [57]. This evidence concerns the gene HLA-G and melanoma.